Overview

Apatinib for the Elderly Advanced Gastric Cancer

Status:
Completed

Trial end date:
2020-06-02

Target enrollment:

Participant gender:

Summary

The purpose of our study is to assess the efficacy and safety of apatinib in elderly advanced gastric cancer patients, and to find the relationship between the expression of VEGFR-2 and efficacy of apatinib treatment.

Phase:

Phase 2

Details

Lead Sponsor:

Affiliated Hospital of Qinghai University

Treatments:

Apatinib